| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.007 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |